Filing Details

Accession Number:
0001765581-22-000092
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-09 18:34:52
Reporting Period:
2022-08-05
Accepted Time:
2022-08-09 18:34:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397661 W Kenneth O'keefe 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-08-05 2,561 $0.00 22,168 No 4 A Direct
Ordinary Shares Disposition 2022-08-08 1,089 $152.33 21,079 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 4,445 Indirect by Trust
Footnotes
  1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023.
  2. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  3. Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.